| Financial Year |
March 31 2023 |
| Monetary Funds |
128,322,164.94 |
| Held-for-trading Financial Assets |
1,140,300.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
152,574,670.50 |
| Advances to Suppliers |
22,752,171.18 |
| Other Receivables |
2,115,154.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
185,884,308.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,796,752.78 |
| Total Current Assets |
526,818,667.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
612,283,294.56 |
| Under-construction Projects |
874,983,230.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
92,883,937.66 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,085,859.09 |
| Deferred Income Tax Assets |
6,688,448.77 |
| Other Non-Current Assets |
11,594,569.00 |
| Sub-Total of Non-Current Assets |
1,695,214,247.90 |
| Total Assets |
2,222,032,915.04 |
| Short-Term Loans |
413,813,076.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
112,756,218.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,234,723.12 |
| Taxes Payable |
10,984,638.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,801,021.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,653,315.13 |
| Other Current Liabilities |
1,782,766.38 |
| Sub-Total of Current Liabilities |
603,821,244.08 |
| Long-term Loans |
57,017,772.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,389,128.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
98,023,884.14 |
| Total Liabilities |
701,845,128.22 |
| Paid-In Capital(Or Share Stock) |
135,478,432.00 |
| Capital Surplus |
933,709,663.45 |
| Surplus Reserve |
60,849,415.33 |
| LESS:Treasury Stock |
28,696,978.80 |
| Undistributed Profits |
408,824,314.34 |
| Minority Stockholder's Interest |
9,037,148.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,511,150,638.07 |
| Owner's Equity（Stockholder's Equity） |
1,520,187,786.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,222,032,915.04 |
